218 related articles for article (PubMed ID: 7032292)
21. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
22. Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells.
De Baetselier P; Gorelik E; Eshhar Z; Ron Y; Katzav S; Feldman M; Segal S
J Natl Cancer Inst; 1981 Nov; 67(5):1079-87. PubMed ID: 6975387
[TBL] [Abstract][Full Text] [Related]
23. [General principles of the technic for obtaining monoclonal antibodies].
Favila Castillo L; Velázquez García P
Salud Publica Mex; 1985; 27(3):185-93. PubMed ID: 3901314
[No Abstract] [Full Text] [Related]
24. [Production of monoclonal antibody with anti-B specificity, to be used as reagent for blood classification].
León G; Cruz C; Rojas L
Invest Clin; 2004 Jun; 45(2):145-57. PubMed ID: 15211982
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
26. [HLA typing and application of monoclonal antibodies].
Ikeda H; Wakisaka A
Nihon Rinsho; 1983; 41(4):841-5. PubMed ID: 6887551
[No Abstract] [Full Text] [Related]
27. Production and characterization of monoclonal antibodies to bovine immunoglobulin G2.
Srikumaran S; Guidry AJ; Goldsby RA
Am J Vet Res; 1982 Jan; 43(1):21-5. PubMed ID: 7091814
[TBL] [Abstract][Full Text] [Related]
28. Use of heterohybridomas in xenotransplantation.
Yang Q; Bollinger RR; De Buysscher EV
Transplant Proc; 1992 Apr; 24(2):457-8. PubMed ID: 1566389
[No Abstract] [Full Text] [Related]
29. [Neoplastic-lymphocytic hybrid cell lines].
Izdebska-Szymona K
Postepy Hig Med Dosw; 1979; 33(5):465-77. PubMed ID: 398040
[No Abstract] [Full Text] [Related]
30. Monoclonal antibodies to the contractile proteins.
Payne MR
Cell Muscle Motil; 1983; 4():137-77. PubMed ID: 6367956
[No Abstract] [Full Text] [Related]
31. Biology of disease. Monoclonal antibodies and tumor-associated antigens.
Damjanov I; Knowles BB
Lab Invest; 1983 May; 48(5):510-25. PubMed ID: 6341710
[No Abstract] [Full Text] [Related]
32. Characterization of a macaque anti-Rh17-like monoclonal antibody.
Blancher A; Roubinet F; Reid ME; Socha WW; Bailly P; Bénard P
Vox Sang; 1998; 75(1):58-62. PubMed ID: 9745155
[TBL] [Abstract][Full Text] [Related]
33. Immunization of normal human splenocytes in vitro to produce human monoclonal antibodies to cellular antigens.
Hulette CM; Effros RB; Walford RL
Tissue Antigens; 1987 Jul; 30(1):25-33. PubMed ID: 3672490
[TBL] [Abstract][Full Text] [Related]
34. [Human monoclonal antibodies directed to lung cancer].
Kudo T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):363-8. PubMed ID: 8109992
[TBL] [Abstract][Full Text] [Related]
35. Improved fusion partners transfected with DNA fragment encoding IL-11 on generation of human B lymphocyte hybridomas.
Zhu Y; Jin B; Jiang S; Sun K; Sun C; Liu X
Hum Antibodies; 1999; 9(1):1-7. PubMed ID: 10331181
[TBL] [Abstract][Full Text] [Related]
36. An improved in vitro immunization procedure for the production of monoclonal antibodies.
Boss BD
Methods Enzymol; 1986; 121():27-33. PubMed ID: 3724466
[No Abstract] [Full Text] [Related]
37. Immunizations of human lymphocytes in vitro with a T-dependent antigen towards human monoclonal antibody production.
Maddaly R; Sivaramakrishnan P; Paul SF
Hum Antibodies; 2009; 18(3):101-7. PubMed ID: 19729804
[TBL] [Abstract][Full Text] [Related]
38. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
39. [T-cell clones and monoclonal antibodies].
Roellinger B
Dtsch Tierarztl Wochenschr; 1987 Apr; 94(4):222-3. PubMed ID: 3297611
[No Abstract] [Full Text] [Related]
40. The optimal technological approach to the development of human hybridomas.
Dorfman NA
J Biol Response Mod; 1985 Jun; 4(3):213-39. PubMed ID: 2991473
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
